A.R.T. Advisors’s Arcadia Biosciences RKDA Stock Holding History

A.R.T. Advisors’s Portfolio RKDA Stock Details RKDA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-343	Closed	-$64K	–	1655
2019 Q3	$64K	Buy	+343	New	+$65.8K	﹤0.01%	1296

Other funds holding RKDA

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

AAP

Ardsley Advisory Partners Stamford, Connecticut $960M AUM 207.76% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

OAM

Oxford Asset Management Oxford, United Kingdom $232M AUM 31% 1-Year Est. Return

Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

A.R.T. Advisors's RKDA Position: Q4 2019 in Review

A.R.T. Advisors sold out of Arcadia Biosciences (RKDA) in Q4 2019, closing a stake of 343 shares — an estimated $64K sold.

A.R.T. Advisors first reported a position in RKDA in Q3 2019 and held it in 1 quarter. The position peaked at $64K in Q3 2019. 14 funds tracked by Wall St. Rank hold RKDA as of Q4 2019.

A.R.T. Advisors reported no remaining Arcadia Biosciences position as of Q4 2019 after selling out during the quarter.
A.R.T. Advisors sold 343 Arcadia Biosciences shares in Q4 2019, an estimated $64K.
A.R.T. Advisors first reported a position in Arcadia Biosciences in Q3 2019 and held it in 1 quarter.
A.R.T. Advisors's Arcadia Biosciences position peaked at $64K in Q3 2019.
14 funds tracked by Wall St. Rank held Arcadia Biosciences as of Q4 2019.

Based on A.R.T. Advisors's 13F filing for Q4 2019, filed 14 Feb 2020.